Antrodia camphorata (syn: A. cinnamomea) is a fungus species from Taiwan, described in 1995, but consumed for centuriesas food and beverages. Following a request from Golden Biotechnology Corp (), EFSA has evaluated the safety of freeze-dried mycelia from A. camphorata for human consumption.
The novel food is intended to be used in food supplements at a maximum dose of 990 mg/day. It is mainly composed of carbohydrates, and contains also significant amounts of beta-glucan, antroquinonol and triterpenoids. The applicant provided several toxicological studies, including genotoxicity tests, in vivo toxicity tests, and a teratogenicity study. Based on the data provided, EFSA considered that the novel food is safe at the proposed conditions of use (990 mg/day) for individuals aged 14 and above.
EFSA NDA Panel (EFSA Panel on Nutrition, Novel Foods and Food Allergens), Turck D, Bohn T, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pelaez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Cubadda F, Frenzel T, Heinonen M, Marchelli R, Neuhauser-Berthold M, Poulsen M, Prieto Maradona M, Schlatter JR, van Loveren H, Turla E and Knutsen HK, 2022. Scientific Opinion on the safety of freeze-dried mycelia of Antrodia camphorate as a novel food pursuant to regulation (EU) 2015/2283. EFSA Journal 2022;20(6):7380.